A review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates

1. Coggins CR. A review of chronic inhalation studies with mainstream
cigarette smoke, in hamsters, dogs, and nonhuman primates. Toxicol
Pathol 2001;29:550–557.
2. Liu J, Johnston MR. Animal models for studying lung cancer and
evaluating novel intervention strategies. Surg Oncol 2002;11:217–227.
3. Coggins CR. An updated review of inhalation studies with cigarette
smoke in laboratory animals. Int J Toxicol 2007;26:331–338.
4. Tuveson DA, Jacks T. Modeling human lung cancer in mice: similarities
and shortcomings. Oncogene 1999;18:5318–5324.
5. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer
Inst 1999;91:1194–11210.
6. Beadsmoore CJ, Screaton NJ. Classification, staging and prognosis of
lung cancer. Eur J Radiol 2003;45:8–17.
7. Malkinson AM, Beer DS. Major effect on susceptibility to urethaninduced
pulmonary adenoma by a single gene in BALB/cBy mice.
J Natl Cancer Inst 1983;70:931–936.
8. You M, Wang Y, Lineen AM, et al. Mutagenesis of the K- ras protooncogene
in mouse lung tumors induced by N-ethyl-N-nitrosourea or
N-nitrosodiethylamine. Carcinogenesis 1992;13:1583–1586.
9. Chen B, You L, Wang Y, et al. Allele-specific activation and expression
of the K- ras gene in hybrid mouse lung tumors induced by chemical
carcinogens. Carcinogenesis 1994;15:2031–2035.
10. Gariboldi M, Manenti G, Canzian F, et al. A major susceptibility locus
to murine lung carcinogenesis maps on chromosome 6. Nat Genet 1993;
3:132–136.
11. Lin L, Festing MF, Devereux TR, et al. Additional evidence that the
K- ras protooncogene is a candidate for the major mouse pulmonary
adenoma susceptibility (Pas-1) gene. Exp Lung Res 1998;24:481–497.
12. Shimkin MB, Stoner GD. Lung tumors in mice: application to carcinogenesis
bioassay. Adv Cancer Res 1975;21:1–58.
13. Malkinson AM. Primary lung tumors in mice: an experimentally
manipulable model of human adenocarcinoma. Cancer Res 1992;52
(9 Suppl):S2670–S2676.
14. Stathopoulos GT, Sherrill TP, Cheng DS, et al. Epithelial NF-kappaB
activation promotes urethane-induced lung carcinogenesis. Proc Natl
Acad Sci U S A 2007;104:18514–18519.
15. Malkinson AM. Primary lung tumors in mice as an aid for understanding,
preventing, and treating human adenocarcinoma of the lung. Lung
Cancer 2001;32:265–279.
16. Hahn FF, Gigliotti AP, Hutt JA, et al. A review of the histopathology
of cigarette smoke-induced lung cancer in rats and mice. Int J Toxicol
2007;26:307–313.
17. Szymanska H, Sitarz M, Krysiak E, et al. Genetics of susceptibility to
radiation-induced lymphomas, leukemias and lung tumors studied in
recombinant congenic strains. Int J Cancer 1999;83:674–678.
18. Todaro GJ, Fryling C, De Larco JE. Transforming growth factors produced
by certain human tumor cells: polypeptides that interact with
epidermal growth factor receptors. Proc Natl Acad Sci U S A 1980;
77:5258–5262.
19. Stoner GD, Adam–Rodwell G, Morse MA. Lung tumors in strain A
mice: application for studies in cancer chemoprevention. J Cell Biochem
Suppl 1993;17F:95–103.
20. Sporn MB, Dunlop NM, Newton DL, et al. Prevention of chemical
carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed
Proc 1976;35:1332–13328.
21. Duperron C, Castonguay A. Chemopreventive efficacies of aspirin
and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis
1997;18:1001–1006.
22. Lantry LE, Zhang Z, Crist KA, et al. 5-Aza-2´-deoxycytidine is chemopreventive
in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced
primary mouse lung tumor model. Carcinogenesis 1999;20:343–346.
23. Kohno H, Taima M, Sumida T, et al. Inhibitory effect of mandarin
juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in
mice. Cancer Lett 2001;174:141–150.
24. Lantry LE, Zhang Z, Gao F, et al. Chemopreventive effect of perillyl
alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced
tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem
Suppl 1997;27:20–25.
25. Manzotti C, Audisio RA, Pratesi G. Importance of orthotopic implantation
for human tumors as model systems: relevance to metastasis and
invasion. Clin Exp Metastasis 1993;11:5–14.
26. Fidler IJ. Host and tumour factors in cancer metastasis. Eur J Clin
Invest 1990;20:481–486.
27. Mase K, Iijima T, Nakamura N, et al. Intrabronchial orthotopic propagation
of human lung adenocarcinoma—characterizations of tumorigenicity,
invasion and metastasis. Lung Cancer 2002;36:271–276.
28. Kozaki K, Miyaishi O, Tsukamoto T, et al. Establishment and characterization
of a human lung cancer cell line NCI-H460-LNM35 with
consistent lymphogenous metastasis via both subcutaneous and orthotopic
propagation. Cancer Res 2000;60:2535–2540.
29. Acuff HB, Carter KJ, Fingleton B, et al. Matrix metalloproteinase-9 from
bone marrow-derived cells contributes to survival but not growth of tumor
cells in the lung microenvironment. Cancer Res 2006;66:259–266.
30. McLemore TL, Liu MC, Blacker PC, et al. Novel intrapulmonary
model for orthotopic propagation of human lung cancers in athymic
nude mice. Cancer Res 1987;47:5132–5140.
31. Kuo TH, Kubota T, Watanabe M, et al. Orthotopic reconstitution of
human small-cell lung carcinoma after intravenous transplantation in
SCID mice. Anticancer Res 1992;12:1407–1410.
32. Doki Y, Murakami K, Yamaura T, et al. Mediastinal lymph node metastasis
model by orthotopic intrapulmonary implantation of Lewis lung
carcinoma cells in mice. Br J Cancer 1999;79:1121–1126.
33. Chen X, Su Y, Fingleton B, et al. An orthotopic model of lung cancer
to analyze primary and metastatic NSCLC growth in integrin alpha1-
null mice. Clin Exp Metastasis 2005;22:185–193.
34. Howard RB, Mullen JB, Pagura ME, et al. Characterization of a highly
metastatic, orthotopic lung cancer model in the nude rat. Clin Exp
Metastasis 1999;17:157–162.
35. Hoffman R. Green fluorescent protein imaging of tumour growth, metastasis,
and angiogenesis in mouse models. Lancet Oncol 2002;3:546–556.
36. El Hilali N, Rubio N, Martinez-Villacampa M, et al. Combined
noninvasive imaging and luminometric quantification of luciferase- labeled
human prostate tumors and metastases. Lab Invest 2002;82:1563–1571.
37. Hoffman RM. Visualization of GFP-expressing tumors and metastasis
in vivo. Biotechniques 2001;30:1016–1022, 1024–1026.
38. Hasegawa S, Yang M, Chishima T, et al. In vivo tumor delivery of the
green fluorescent protein gene to report future occurrence of metastasis.
Cancer Gene Ther 2000;7:1336–1340.
39. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, et al. Animal models of
bone metastasis. Cancer 2003;97:748–757.
40. Sarkioja M, Kanerva A, Salo J, et al. Noninvasive imaging for evaluation
of the systemic delivery of capsid-modified adenoviruses in
an orthotopic model of advanced lung cancer. Cancer 2006;107:
1578–1588.
41. Kubota T. Metastatic models of human cancer xenografted in the nude
mouse: the importance of orthotopic transplantation. J Cell Biochem
1994;56:4–8.
42. Liu J, Costello PC, Pham NA, et al. Integrin-linked kinase inhibitor
KP-392 demonstrates clinical benefits in an orthotopic human nonsmall
cell lung cancer model. J Thorac Oncol 2006;1:771–779.
43. Wu W, Onn A, Isobe T, et al. Targeted therapy of orthotopic human
lung cancer by combined vascular endothelial growth factor and epidermal
growth factor receptor signaling blockade. Mol Cancer Ther
2007;6:471–483.
44. Zou Y, Tornos C, Qiu X, et al. P53 aerosol formulation with low toxicity
and high efficiency for early lung cancer treatment. Clin Cancer Res
2007;13:4900–4908.
45. Kohno T, Yokota J. How many tumor suppressor genes are involved in
human lung carcinogenesis? Carcinogenesis 1999;20:1403–1410.
46. Salgia R, Skarin AT. Molecular abnormalities in lung cancer. J Clin
Oncol 1998;16:1207–1217.
47. Wikenheiser KA, Clark JC, Linnoila RI, et al. Simian virus 40 large
T antigen directed by transcriptional elements of the human surfactant
protein C gene produces pulmonary adenocarcinomas in transgenic
mice. Cancer Res 1992;52:5342–5352.
48. Saitoh A, Kimura M, Takahashi R, et al. Most tumors in transgenic
mice with human c-Ha-ras gene contained somatically activated transgenes.
Oncogene 1990;5:1195–1200.
49. Lubet RA, Zhang Z, Wiseman RW, et al. Use of p53 transgenic mice
in the development of cancer models for multiple purposes. Exp Lung
Res 2000;26:581–593.
50. Tchou-Wong KM, Jiang Y, Yee H, et al. Lung-specific expression of
dominant-negative mutant p53 in transgenic mice increases spontaneous
and benzo[a]pyrene-induced lung cancer. Am J Respir Cell Mol Biol
2002;27:186–193.
51. Zhang Z, Liu Q, Lantry LE, et al. A germ-line p53 mutation accelerates
pulmonary tumorigenesis: p53 -independent efficacy of
chemopreventive agents green tea or dexamethasone/myo- inositol
and chemotherapeutic agents taxol or adriamycin. Cancer Res 2000;
60:901–907.
52. Spitz MR, Barnett MJ, Goodman GE, et al. Serum insulin-like
growth factor (IGF) and IGF-binding protein levels and risk of lung
cancer: a case-control study nested in the beta-carotene and Retinol
Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev 2002;
11:1413–1418.
53. Moorehead RA, Sanchez OH, Baldwin RM, et al. Transgenic overexpression
of IGF-II induces spontaneous lung tumors: a model for
human lung adenocarcinoma. Oncogene 2003;22:853–857.
54. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53
are developmentally normal but susceptible to spontaneous tumours.
Nature 1992;356:215–221.
55. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor
suppression and cell mortality. Cell 1996;85:27–37.
56. Williams BO, Remington L, Albert DM, et al. Cooperative tumorigenic
effects of germline mutations in Rb and p53 . Nat Genet
1994;7:480–484.
57. Aguayo SM, Miller YE, Waldron JA Jr, et al. Brief report: idiopathic
diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease.
N Engl J Med 1992;327:1285–1288.
58. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of
the K- ras oncogene causes early onset lung cancer in mice. Nature
2001;410:1111–1116.
59. Wislez M, Fujimoto N, Izzo JG, et al. High expression of ligands for
chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by
oncogenic kras. Cancer Res 2006;66:4198–4207.
60. Fujimoto N, Wislez M, Zhang J, et al. High expression of ErbB family
members and their ligands in lung adenocarcinomas that are sensitive
to inhibition of epidermal growth factor receptor. Cancer Res 2005;
65:11478–11485.
61. Pandey J, Umphress SM, Kang Y, et al. Modulation of tumor induction
and progression of oncogenic K- ras -positive tumors in the
presence of TGF-b1 haploinsufficiency. Carcinogenesis 2007;28:
2589–2596.
62. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation
and progression using conditional expression of oncogenic K- ras . Genes
Dev 2001;15:3243–3248.
63. Meuwissen R, Linn SC, van der Valk M, et al. Mouse model for lung
tumorigenesis through Cre/lox controlled sporadic activation of the
K- ras oncogene. Oncogene 2001;20:6551–6558.
64. Kissil JL, Walmsley MJ, Hanlon L, et al. Requirement for Rac1 in a K- ras
induced lung cancer in the mouse. Cancer Res 2007;67:8089–8094.
65. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation
and metastasis. Nature 2007;448:807–810.
66. Lyons SK, Meuwissen R, Krimpenfort P, et al. The generation
of a conditional reporter that enables bioluminescence imaging
of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003;
63:7042–7046.
67. Meuwissen R, Linn SC, Linnoila RI, et al. Induction of small cell lung
cancer by somatic inactivation of both Tr p53 and Rb1 in a conditional
mouse model. Cancer Cell 2003;4:181–189.
68. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes
Dev 2005;19:643–664.
69. Lifsted T, Le Voyer T, Williams M, et al. Identification of inbred mouse
strains harboring genetic modifiers of mammary tumor age of onset
and metastatic progression. Int J Cancer 1998;77:640–644.
70. Le Voyer T, Rouse J, Lu Z, et al. Three loci modify growth of a transgene-
induced mammary tumor: suppression of proliferation associated
with decreased microvessel density. Genomics 2001;74:253–261.